(Q35498077)

8 August 2017

title

Acute decline in serum sclerostin in response to PTH infusion in healthy men. (English)

1 reference

8 August 2017

Elaine W Yu

1

1 reference

8 August 2017

Ruchit Kumbhani

series ordinal

2

1 reference

8 August 2017

Erica Siwila-Sackman

series ordinal

3

1 reference

8 August 2017

Benjamin Z Leder

series ordinal

4

1 reference

8 August 2017

language of work or name

English

0 references

publication date

24 August 2011

1 reference

The Journal of Clinical Endocrinology and Metabolism

8 August 2017

published in

1 reference

8 August 2017

volume

96

1 reference

8 August 2017

issue

11

1 reference

8 August 2017

page(s)

E1848-51

1 reference

Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Control of bone mass and remodeling by PTH receptor signaling in osteocytes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Control of the SOST bone enhancer by PTH using MEF2 transcription factors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

SOST is a target gene for PTH in bone

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205893

Skeletal disease in primary hyperparathyroidism

26 September 2018

1 reference

12 December 2020

Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone

1 reference

12 December 2020

Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls

1 reference

12 December 2020

The Waning of Teriparatide Effect on Bone Formation Markers in Postmenopausal Osteoporosis Is Associated with Increasing Serum Levels of DKK1

1 reference

12 December 2020

Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide

1 reference

12 December 2020

Estrogen Protection against Bone Resorbing Effects of Parathyroid Hormone Infusion: Assessment by Use of Biochemical Markers

1 reference

12 December 2020

Identifiers

DOI

10.1210/JC.2011-1534

1 reference

8 August 2017

1 reference

8 August 2017

1 reference